相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Stimulation of the soluble guanylate cyclase (sGC) inhibits fibrosis by blocking non-canonical TGFβ signalling
Christian Beyer et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Inhibition of casein kinase II reduces TGFβ induced fibroblast activation and ameliorates experimental fibrosis
Yun Zhang et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Activation of liver X receptors inhibits experimental fibrosis by interfering with interleukin-6 release from macrophages
Christian Beyer et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
SIRT1 protects against cigarette smoke-induced lung oxidative stress via a FOXO3-dependent mechanism
Hongwei Yao et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2014)
Heat shock protein 90 (Hsp90) inhibition targets canonical TGF-β signalling to prevent fibrosis
Michal Tomcik et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Inactivation of evenness interrupted (EVI) reduces experimental fibrosis by combined inhibition of canonical and non-canonical Wnt signalling
Alfiya Distler et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
The Wnt antagonists DKK1 and SFRP1 are downregulated by promoter hypermethylation in systemic sclerosis
Clara Dees et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Combined inhibition of morphogen pathways demonstrates additive antifibrotic effects and improved tolerability
Alfiya Distler et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Sirt1 Activation Ameliorates Renal Fibrosis by Inhibiting the TGF-β/Smad3 Pathway
Xin-Zhong Huang et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2014)
Blockade of canonical Wnt signalling ameliorates experimental dermal fibrosis
Christian Beyer et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative
Frank van den Hoogen et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
SIRT1 inhibits TNF-α-induced apoptosis of vascular adventitial fibroblasts partly through the deacetylation of FoxO1
Weirong Wang et al.
APOPTOSIS (2013)
TGF-beta signaling in tissue fibrosis: Redox controls, target genes and therapeutic opportunities
Rohan Samarakoon et al.
CELLULAR SIGNALLING (2013)
Sirt1 resists advanced glycation end products-induced expressions of fibronectin and TGF-β1 by activating the Nrf2/ARE pathway in glomerular mesangial cells
Kaipeng Huang et al.
FREE RADICAL BIOLOGY AND MEDICINE (2013)
Crosstalk between Oxidative Stress and SIRT1: Impact on the Aging Process
Antero Salminen et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
SIRT1 Suppresses the Epithelial-to-Mesenchymal Transition in Cancer Metastasis and Organ Fibrosis
Petra Simic et al.
CELL REPORTS (2013)
Inhibition of hedgehog signalling prevents experimental fibrosis and induces regression of established fibrosis
Angelika Horn et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Stimulation of soluble guanylate cyclase reduces experimental dermal fibrosis
Christian Beyer et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Jun N-terminal kinase as a potential molecular target for prevention and treatment of dermal fibrosis
Nicole Reich et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Inactivation of fatty acid amide hydrolase exacerbates experimental fibrosis by enhanced endocannabinoid-mediated activation of CB1
Katrin Palumbo-Zerr et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Pomalidomide is effective for prevention and treatment of experimental skin fibrosis
Simon Weingaertner et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Inhibition of activator protein 1 signaling abrogates transforming growth factor β-mediated activation of fibroblasts and prevents experimental fibrosis
Jerome Avouac et al.
ARTHRITIS AND RHEUMATISM (2012)
Hedgehog signaling controls fibroblast activation and tissue fibrosis in systemic sclerosis
Angelika Horn et al.
ARTHRITIS AND RHEUMATISM (2012)
JAK-2 as a Novel Mediator of the Profibrotic Effects of Transforming Growth Factor β in Systemic Sclerosis
Clara Dees et al.
ARTHRITIS AND RHEUMATISM (2012)
Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis
Alfiya Akhmetshina et al.
NATURE COMMUNICATIONS (2012)
The transcription factor JunD mediates transforming growth factor β-induced fibroblast activation and fibrosis in systemic sclerosis
Katrin Palumbo et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
SIRT1 overexpression in the rheumatoid arthritis synovium contributes to proinflammatory cytokine production and apoptosis resistance
Fabienne Niederer et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Notch signalling regulates fibroblast activation and collagen release in systemic sclerosis
Clara Dees et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Inhibition of Notch Signaling Prevents Experimental Fibrosis and Induces Regression of Established Fibrosis
Clara Dees et al.
ARTHRITIS AND RHEUMATISM (2011)
Platelet-derived serotonin links vascular disease and tissue fibrosis
Clara Dees et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Resveratrol Inhibits Renal Fibrosis in the Obstructed Kidney Potential Role in Deacetylation of Smad3
Jinhua Li et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database
Anthony J. Tyndall et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Animal Models of Systemic Sclerosis Prospects and Limitations
Christian Beyer et al.
ARTHRITIS AND RHEUMATISM (2010)
The Transcription Factor Fra-2 Regulates the Production of Extracellular Matrix in Systemic Sclerosis
Nicole Reich et al.
ARTHRITIS AND RHEUMATISM (2010)
SIRT1 modulates expression of matrix metalloproteinases in human dermal fibroblasts
K. Ohguchi et al.
BRITISH JOURNAL OF DERMATOLOGY (2010)
Peroxisome proliferator- activated receptor γ: innate protection from excessive fibrogenesis and potential therapeutic target in systemic sclerosis
Jun Wei et al.
CURRENT OPINION IN RHEUMATOLOGY (2010)
SRT1720, SRT2183, SRT1460, and Resveratrol Are Not Direct Activators of SIRT1
Michelle Pacholec et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
The Cannabinoid Receptor CB2 Exerts Antifibrotic Effects in Experimental Dermal Fibrosis
Alfiya Akhmetshina et al.
ARTHRITIS AND RHEUMATISM (2009)
Resveratrol is Not a Direct Activator of SIRT1 Enzyme Activity
Dirk Beher et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2009)
Resveratrol augments the canonical Wnt signaling pathway in promoting osteoblastic differentiation of multipotent mesenchymal cells
Haibin Zhou et al.
EXPERIMENTAL CELL RESEARCH (2009)
Mechanisms of Disease: Scleroderma.
Armando Gabrielli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Sirt1 protects against oxidative stress-induced renal tubular cell apoptosis by the bidirectional regulation of catalase expression
Kazuhiro Hasegawa et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Sirtuins - novel therapeutic targets to treat age-associated diseases
Siva Lavu et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
SIRT1 inhibits transforming growth factor β-induced apoptosis in glomerular mesangial cells via Smad7 deacetylation
Shinji Kume et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Postnatal induction of transforming growth factor beta signaling in fibroblasts of mice recapitulates clinical, histologic, and biochemical features of scleroderma
Sonali Sonnylal et al.
ARTHRITIS AND RHEUMATISM (2007)
Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis
Joerg H. W. Distler et al.
ARTHRITIS AND RHEUMATISM (2007)
The Sir2 family of protein deacetylases
G Blander et al.
ANNUAL REVIEW OF BIOCHEMISTRY (2004)
分享论文
